Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors

Annals of Hematology

Volumn 85, Issue 1, 2006, Pages 32-37

  Siegling, Sabine ^a   Thyzel, Elmar ^a   Glahn, Joerg ^b   Kleesiek, Knut ^a   Götting, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b KLINIKUM MINDEN   (Germany)

Author keywords

Mutational screening; Promoter; Sequence variations; Tissue factor pathway inhibitor 2 (TFPI 2)

Indexed keywords

ALKALINE PHOSPHATASE; GENOMIC DNA; PLACENTA PROTEIN 5; SERINE PROTEINASE INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR SP1;

ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD DONOR; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE CONTROL; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TFPI 2 GENE;

EID: 28944442541     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-0023-y     Document Type: Article

References (23)

1. Voetsch B, Loscalzo J (2004) Genetic determinants of arterial thrombosis. Arteriosler Thromb Vasc Biol 24:216-229 10.1161/ 01.ATV.0000107402.79771.fc
2. Sprecher CA, Kisiel W, Mathewes S, Foster DC (1994) Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway-inhibitor. Proc Natl Acad Sci U S A 91:3353-3357 8159751
3. Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W (1996) Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 35:266-272 10.1021/bi951501d
4. Blindt R, Vogt F, Lamby D, Zeiffer U, Krott N, Hilger-Eversheim K, Hanrath P, vom Dahl J, Bosserhoff AK (2002) Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res 39:340-352 10.1159/000065546
5. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143 10.1161/hc0902.104353
6. DeGraba TJ (2004) Immunogenetic susceptibility of atherosclerotic stroke. Implication on current and future treatment of vascular inflammation. Stroke 35:2712-2719 10.1161/01.STR.0000143788.87054.85
7. Crawley JTB, Goulding DA, Ferreira V, Severs NJ, Lupu F (2002) Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 22:218-224 10.1161/hq0102.101842
8. Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W (1996) Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 35:266-272 10.1021/bi951501d
9. Herman MP, Sukhova G, Kisiel W, Foster D, Kehry MR, Libby P, Schönbeck U (2001) Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107:1117-1126 11342575
10. Peeschke EIB, Petrovan RJ, Ghebrehiwet B, Ruf W (2004) Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gCIqR/p33 (gCIqR): Implications for vascular inflammation. Thromb Haemost 92:811-819 15467913
11. Konduri SD, Rao CN, Chandrasekar N, Tasiou A, Mohanam S, Kin Y, Lakka SS, Dinh D, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS (2001) A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene 20:6938-6945 10.1038/sj.onc.1204847
12. Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS (2001) Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clin Cancer Res 7:570-576 11297250
13. Miyagi Y, Yasumitsu H, Eki T, Miyata S, Kkawa N, Hirahara F, Aoki I, Misugi K, Miyazaki K (1996) Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human rodent cell hybrid mapping panel analysis. Genomics 35:267-268 10.1006/geno.1996.0353
14. Kamei S, Kazama Y, Kuijper JL, Foster DC, Kisiel W (2001) Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene. Biochim Biophys Acta 1517:430-435 11342222
15. Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y (2003) Characterization and functional analysis of TFPI-2 gene promoter in human choriocarcinoma cell line. Thromb Res 109:207-215 10.1016/ S0049-3848(03)00147-6
16. Kleesiek K, Schmidt M, Götting C, Brinkmann T, Prohaska W (1998) A first mutation in the human tissue factor pathway inhibitor gene encoding [P151L]TFPI. Blood 92:3976-3977 9867356
17. Moatti D, Seknadji P, Galand C, Poirier O, Fumeron F, Desprez S, Garbarz M, Dhermy D, Arveiler D, Evans A, Luc G, Ruidavets JB, Oliver V, Hakim J, Aumont MC, de Prost D (1999) Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects: Impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol 19:862-869 10195910
18. Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimura H, Kawasaki T, Kato H (1998) C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb Haemost 80:345-346 9716167
19. Moatti D, Haidar B, Fumeron F, Gauci L, Boudvillain O, Seknadji P, Oliver V, Aumont MC, de Prost D (2000) A new T-287C polymorphism in the 5′ regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphism with coronary attire disease and plasma TFPI levels. Thromb Haemost 84:244-249 10959696
20. Hatano S (1976) Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ 54:541-543 1088404
21. Kleesiek K, Schmidt M, Götting C, Schwenz B, Lange S, Müller-Berghaus G, Brinkmann T, Prohaska W (1999) The 536C→ transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 82:1-5
22. Schug J, Overton GC (1997) TESS: Transcriptional Element Search Software on the WWW, Technical report CBIL-TR-1997-1001-v0.0. Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania
23. Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrat M, Foster D, Kisiel W, Rao JS (2003) Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells. Int J Oncol 22:1277-1283 12738994